Generic Growth Opportunities are Significant, with an Estimated $100bn Worth of Branded Pharmaceutical Products to go off Patent by 2010, of which $21bn Expire in 2006.DUBLIN Dublin, city, Republic of Ireland Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River. , Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c35683) has announced the addition of "The Top 10 Generics Companies: Strategic Insight, Growth Opportunities and Competitive Dynamics in the US and Europe" to their offering. The generics sector has grown at a fast pace over the past few years, outperforming the pharmaceutical market as a whole; generic growth opportunities are significant, with an estimated $100bn worth of branded pharmaceutical products to go off patent by 2010, of which $21bn expire expire /ex·pire/ (ek-spi´er) 1. to exhale. 2. to die. ex·pire v. 1. To breathe one's last breath; die. 2. To exhale. in 2006. Although US and major European European emanating from or pertaining to Europe. European bat lyssavirus see lyssavirus. European beech tree fagussylvaticus. European blastomycosis see cryptococcosis. generic drug generic drug, a drug sold or prescribed under the nonproprietary name of its active ingredients or under a generally descriptive name rather than under a brand or trade name. sales increased rapidly from 2000 to 2003, there has been a slowdown For articles with similar titles, see Slow Down (disambiguation). A slowdown is an industrial action in which employees perform their duties but seek to reduce productivity or efficiency in their performance of these duties. in growth during 2004. In response to an increasingly competitive unbranded generic pharmaceutical marketplace, and a slowdown in growth in 2004, some of the major generics players have consolidated. The two largest M&A deals in the generics market in recent years have been the acquisition of Eon and HEXAL Labs by Sandoz in February 2005, and the acquisition of IVAX IVAX Industrial Vax (Dec Computer) by Teva in January 2006. "The Top 10 Generics Companies: Strategic Insight, Growth Opportunities and Competitive Dynamics in the US and Europe" identifies the successful strategies utilized by the industry's key players in the US and Western European market. The report provides insights into the top 10 generic companies strengths, weaknesses, opportunities and threats in the generic pharmaceutical market, allowing you to tailor A tailor is a person whose occupation is to sew menswear style jackets and the skirts or trousers that go with them. Although the term dates to the thirteenth century, tailor the best practice strategies of the generic industry's leading players to your company's needs. Key topics covered: - The generics market in US and Europe - Teva/IVAX - Sandoz (incl. Eon Labs and HEXAL) - Mylan - Ratiopharm - Watson Pharmaceuticals Inc. - Par Pharmaceuticals, Inc. - Merck KGaA - Baxter International Inc. - STADA - Apotex For more information visit http://www.researchandmarkets.com/reports/c35683 Source: Business Insights |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion